GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » L&C BIO Co Ltd (XKRX:290650) » Definitions » Ending Cash Position

L&C BIO Co (XKRX:290650) Ending Cash Position : ₩10,147 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is L&C BIO Co Ending Cash Position?

L&C BIO Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩10,147 Mil.

L&C BIO Co's quarterly Ending Cash Position increased from Sep. 2023 (₩14,050 Mil) to Dec. 2023 (₩14,949 Mil) but then declined from Dec. 2023 (₩14,949 Mil) to Mar. 2024 (₩10,147 Mil).

L&C BIO Co's annual Ending Cash Position declined from Dec. 2021 (₩17,382 Mil) to Dec. 2022 (₩6,592 Mil) but then increased from Dec. 2022 (₩6,592 Mil) to Dec. 2023 (₩14,949 Mil).


L&C BIO Co Ending Cash Position Historical Data

The historical data trend for L&C BIO Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

L&C BIO Co Ending Cash Position Chart

L&C BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 12,766.06 22,266.11 17,381.92 6,591.99 14,949.46

L&C BIO Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,343.79 5,744.82 14,049.80 14,949.46 10,147.17

L&C BIO Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

L&C BIO Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=6591.993+8357.465
=14,949

L&C BIO Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=14949.458+-4802.286
=10,147


L&C BIO Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of L&C BIO Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


L&C BIO Co (XKRX:290650) Business Description

Traded in Other Exchanges
N/A
Address
Suntechcity, Suite No. 605, 606, 607, 474 Dunchon-daero Jungwon-gu, Gyeonggi-do, Seongnam-Si, KOR
L&C BIO Co Ltd manufactures and distributes medical equipment.

L&C BIO Co (XKRX:290650) Headlines

No Headlines